NOTCH3 and ovarian cancer: In the current study, we found that miR-150 targets Notch3, and that the artificial overexpression of miR-150 enhanced PTX sensitivity in PTX-resistant ovarian cancer cells by inhibiting proliferation and promoting apoptosis.